![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/deb18bea-606c-45e0-9485-ea92b4f8efeb/e927tab01.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution
![Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics](https://www.frontiersin.org/files/Articles/431147/fped-07-00011-HTML/image_m/fped-07-00011-g001.jpg)
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame
![Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d113c51-9037-44ef-bf21-ef221a51cd49/gr1.gif)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
![Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis - The Lancet Child & Adolescent Health Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis - The Lancet Child & Adolescent Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/bd4f46de-5e75-4816-8e13-359cf2c4b595/gr1.jpg)